全文获取类型
收费全文 | 4509篇 |
免费 | 226篇 |
国内免费 | 39篇 |
专业分类
耳鼻咽喉 | 57篇 |
儿科学 | 66篇 |
妇产科学 | 43篇 |
基础医学 | 587篇 |
口腔科学 | 121篇 |
临床医学 | 289篇 |
内科学 | 1224篇 |
皮肤病学 | 39篇 |
神经病学 | 292篇 |
特种医学 | 135篇 |
外科学 | 690篇 |
综合类 | 20篇 |
预防医学 | 143篇 |
眼科学 | 28篇 |
药学 | 338篇 |
中国医学 | 10篇 |
肿瘤学 | 692篇 |
出版年
2023年 | 34篇 |
2022年 | 62篇 |
2021年 | 108篇 |
2020年 | 52篇 |
2019年 | 59篇 |
2018年 | 77篇 |
2017年 | 65篇 |
2016年 | 89篇 |
2015年 | 101篇 |
2014年 | 114篇 |
2013年 | 132篇 |
2012年 | 244篇 |
2011年 | 256篇 |
2010年 | 149篇 |
2009年 | 123篇 |
2008年 | 234篇 |
2007年 | 253篇 |
2006年 | 260篇 |
2005年 | 266篇 |
2004年 | 302篇 |
2003年 | 255篇 |
2002年 | 251篇 |
2001年 | 129篇 |
2000年 | 100篇 |
1999年 | 123篇 |
1998年 | 73篇 |
1997年 | 65篇 |
1996年 | 58篇 |
1995年 | 45篇 |
1994年 | 40篇 |
1993年 | 37篇 |
1992年 | 49篇 |
1991年 | 54篇 |
1990年 | 39篇 |
1989年 | 44篇 |
1988年 | 49篇 |
1987年 | 35篇 |
1986年 | 37篇 |
1985年 | 47篇 |
1984年 | 27篇 |
1983年 | 28篇 |
1982年 | 22篇 |
1981年 | 11篇 |
1980年 | 16篇 |
1979年 | 21篇 |
1978年 | 14篇 |
1974年 | 13篇 |
1971年 | 14篇 |
1969年 | 11篇 |
1968年 | 12篇 |
排序方式: 共有4774条查询结果,搜索用时 15 毫秒
991.
Inhibition of Liver Metastasis of Human Gastric Carcinoma by Angiogenesis Inhibitor TNP-470 总被引:1,自引:2,他引:1
Takayuki Shishido Takahiro Yasoshima Ryuichi Denno Noriyuki Sato Koichi Hirata 《Cancer science》1996,87(9):958-962
The anti-tumor and anti-metastatic effects of TNP-470, an angiogenesis inhibitor, and mitomycin C (MMC), a representative anti-neoplastic agent, were investigated using our established liver-metastasizing gastric carcinoma line, AZ-H5c. AZ-H5c was injected into the spleen of nude mice which had been randomly divided into 4 groups; a control group given saline solution, a group receiving 15 mg/kg TNP-470, a group receiving 30 mg/kg TNP-470 and a group receiving 2 mg/kg MMC. TNP-470 was given s.c. on alternate days for 5 weeks from day 10 after intrasplenic injection, and MMC was administered intraperitoneally (i.p.) once a week from day 10 after intrasplenic injection. In the control group, liver metastasis developed in 13 of 16 mice (81%). Liver metastasis developed in 6 of 11 mice (55%) receiving MMC. In contrast, liver metastasis developed in 4 of 8 mice (50%) receiving 15 mg/Kg TNP-470, and in 0 of 14 mice (0%) receiving 30 mg/kg TNP-470. However, TNP-470 had no effect on the tumor growth. These results indicate that the angiogenesis inhibitor TNP-470 has a strong inhibitory activity against in vivo liver metastasis of human gastric carcinoma. 相似文献
992.
OLFM4, LY6D and S100A7 as potent markers for distant metastasis in estrogen receptor‐positive breast carcinoma
下载免费PDF全文
![点击此处可从《Cancer science》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Akifumi Mayama Kiyoshi Takagi Hiroyoshi Suzuki Ai Sato Yoshiaki Onodera Yasuhiro Miki Minako Sakurai Takanori Watanabe Kazuhiro Sakamoto Ryuichi Yoshida Takanori Ishida Hironobu Sasano Takashi Suzuki 《Cancer science》2018,109(10):3350-3359
Metastatic breast cancer is a highly lethal disease, and it is very important to evaluate the biomarkers associated with distant metastasis. However, molecular features of distant metastasis remain largely unknown in breast cancer. Estrogens play an important role in the progression of breast cancer and the majority of stage IV breast carcinomas express estrogen receptor (ER). Therefore, in this study, we examined molecular markers associated with distant metastasis in ER‐positive breast carcinoma by microarray and immunohistochemistry. When we examined the gene expression profile of ER‐positive stage IV breast carcinoma tissues (n = 7) comparing ER‐positive stage I‐III cases (n = 11) by microarray analysis, we newly identified OLFM4, LY6D and S100A7, which were closely associated with the distant metastasis. Subsequently, we performed immunohistochemistry for OLFM4, LY6D and S100A7 in 168 ER‐positive breast carcinomas. OLFM4, LY6D and S100A7 immunoreactivities were significantly associated with stage, pathological T factor, distant metastasis and Ki67 status in the ER‐positive breast carcinomas. Moreover, these immunoreactivities were significantly associated with a worse prognostic factor for distant metastasis‐free and breast cancer‐specific survival in ER‐positive stage I‐III breast cancer patients. However, when we performed immunohistochemistry for OLFM4, LY6D and S100A7 in 40 ER‐negative breast carcinomas, these immunoreactivities were not generally associated with the clinicopathological factors examined, including distant metastasis and prognosis of patients, in this study. These results suggest that OLFM4, LY6D and S100A7 immunoreactivity are associated with an aggressive phenotype of ER‐positive breast carcinoma, and these are potent markers for distant metastasis of ER‐positive breast cancer patients. 相似文献
993.
Yutaka Muto Eri Hagiwara Tomohisa Baba Yozo Sato Masashi Sakayori Erina Tabata Akimasa Sekine Shigeru Komatsu Koji Okudela Koichi Sayama Takashi Ogura 《Internal medicine (Tokyo, Japan)》2022,61(20):3095
A 61-year-old patient with cystic bronchiectasis and bronchial artery hyperplasia in the left lung was diagnosed with polymyositis-related interstitial lung disease. After nine months of immunosuppressive therapy, he developed unilateral autoimmune pulmonary alveolar proteinosis (APAP) in the right lung with respiratory failure. After bronchial artery embolization to prevent massive hemoptysis, whole-lung lavage was performed using veno-venous extracorporeal membrane oxygenation. His respiratory condition improved, and he was discharged from the hospital with supplemental oxygen. Three reported cases of APAP with polymyositis-related interstitial lung disease, including the present case, were all positive for anti-glycyl tRNA synthetase antibody and were under immunosuppressive treatment. 相似文献
994.
995.
Ayaka Motomura Yuki Nakaya Clarence Sampson Takuma Higo Maki Torimoto Hideaki Tsuneki Shinya Furukawa Yasushi Sekine 《RSC advances》2022,12(44):28359
Dry reforming of methane (DRM) is a promising reaction able to convert greenhouse gases (CO2 and CH4) into syngas: an important chemical feedstock. Several difficulties limit the applicability of DRM in conventional thermal catalytic reactions; it is an endothermic reaction that requires high temperatures, resulting in high carbon deposition and a low H2/CO ratio. Catalysis with the application of an electric field (EF) at low temperatures can resolve these difficulties. Synergistic effects with alloys have also been reported for reactions promoted by the application of EF. Therefore, the synergistic effects of low-temperature DRM and Ni–Fe bimetallic catalysts were investigated using various methods and several characterisations (XRD, XPS, FE-STEM, etc.), which revealed that Ni–Fe binary catalysts show high performance in low-temperature DRM. In particular, the Ni0.8Fe0.2 catalyst supported on CeO2 was found to carry out DRM in EF effectively and selectively by virtue of its bimetallic characteristics.Dry reforming of methane (DRM) is a promising reaction able to convert greenhouse gases (CO2 and CH4) into syngas: an important chemical feedstock. 相似文献
996.
997.
ObjectivesEosinophilic otitis media (EOM) is an intractable otitis media mostly associated with bronchial asthma. Dupilumab, an anti-interleukin (IL)-4 receptor (R)α, is effective and has been approved for use in patients with moderate to severe bronchial asthma, atopic dermatitis and chronic rhinosinusitis with nasal polyposis, whose diseases are not controlled by previous treatments including other molecular targeted drugs. We aimed to assess efficacy of dupilumab in three EOM patients with associated bronchial asthma, who were poor responders to previous topical and systemic corticosteroid therapy and molecular targeted therapies.Patients and methodsThree patients with severe, refractory EOM (two with a granulation type) associated with bronchial asthma received dupilumab as add-on therapy for at least 6 months. The efficacy of dupilumab therapy was evaluated using severity scores, symptom scores, hearing acuities, temporal bone computed tomography (CT) scores, and surrogate markers before and after therapy.ResultsSeverity scores in all patients were dramatically reduced to 2 points or less (full score: 16 points) after initiation of therapy. Air conduction hearing levels were improved in all patients. Temporal bone CT scores in two patients were reduced, and serum IgE levels in all three patients also decreased following therapy.ConclusionWe provide the first report that add-on dupilumab therapy was effective in patients with severe, refractory EOM who did not respond to the treatments including other molecular targeted therapy. Patients with severe middle ear mucosal change may benefit particularly from dupilumab therapy. 相似文献
998.
Yumiko Kinoshita Tomoko Ohkusa Rieko Izukura Akiko Chishaki Ryuichi Mibu 《Journal of psychosocial oncology》2017,35(4):468-482
We examined the effects of adjuvant chemotherapy on the health-related quality of life (HRQOL) of lower rectal cancer patients receiving sphincter-saving surgery (SSS). In all, 109 patients completed a questionnaire before surgery and 1, 6, and 12 months afterwards. In the chemotherapy group, physical and social functioning scores were significantly lower 12 months after surgery compared with the nonchemotherapy group. These effects of adjuvant chemotherapy suggest that a different clinical approach might more effectively improve physical and social functioning in lower-rectal cancer patients undergoing chemotherapy. Healthcare providers should be alert for adverse events in patients with lower-rectal cancer and promptly address such conditions. 相似文献
999.
ABSTRACT Home care workers’ (HCWs) approaches to home care users’ acute symptoms are critical for users’ safety and quality of life. However, the processes of these approaches are unclear. This study investigates how HCWs assess users’ conditions. Focus group discussions and semi-structured interviews with HCWs were conducted in a rural Japanese city. HCWs’ decisions were affected by interactions and previous relationships with care managers, home care nurses, physicians, and users’ families. Rural HCWs act flexibly, changing the professionals and families they consult with. Understanding HCWs’ behaviors and improving relationships among medical/care professionals and families can improve management of users’ acute conditions. 相似文献
1000.
Kazuyuki Matsumoto Hironari Kato Seiji Kawano Hiroyasu Fujiwara Kenji Nishida Ryo Harada Masakuni Fujii Ryuichi Yoshida Yuzo Umeda Shiro Hinotsu Takahito Yagi Hiroyuki Okada 《Digestive endoscopy》2020,32(3):425-430
Endoscopic ultrasonography (EUS)-guided ethanol injection was recently proposed for treatment of patients with small pancreatic neuroendocrine tumors (p-NET); however, tips on how to carry out safe and effective procedures are unclear. We launched a pilot study for scheduled early EUS-guided ethanol reinjection for small p-NET. Major eligibility criteria were presence of pathologically diagnosed grade (G) 1 or G2, tumor size ≤2 cm and being a poor or rejected candidate for surgery. For the treatment, we used a 25-gauge needle and pure ethanol. Contrast-enhanced computed tomography (CE-CT) was carried out on postoperative day 3, and if enhanced areas of the tumor were still apparent, an additional session was scheduled during the same hospitalization period. Primary endpoint was complete ablation rate at 1 month after treatment, and secondary endpoint was procedure-related adverse events. A total of five patients were treated. Median size of the tumor was 10 (range: 7–14) mm. Of the five patients, three underwent an additional session. Median volume of ethanol injection per session was 0.8 (range: 0.3–1.0) mL, and the total was 1.0 (0.9–1.8) mL. Complete ablation was achieved in four of the five tumors (80%) with no adverse events. During 1 year of follow up, none of the patients reported any procedure-related adverse events, and no recurrence of tumor. Scheduled early EUS-guided ethanol reinjection appears to be safe and effective for treating small p-NET (UMIN number: 000018834). 相似文献